Bellevue Group AG - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 238 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2021$1,607,000
-5.5%
65,9000.0%0.02%
-11.1%
Q1 2021$1,700,000
-29.2%
65,900
+46.8%
0.02%
-33.3%
Q4 2020$2,400,000
+29.6%
44,9000.0%0.03%
+3.8%
Q3 2020$1,852,000
-14.9%
44,9000.0%0.03%
-16.1%
Q2 2020$2,176,000
+22.6%
44,900
+6.9%
0.03%
-8.8%
Q1 2020$1,775,000
+3.7%
42,000
+5.0%
0.03%
+25.9%
Q4 2019$1,711,000
-47.4%
40,000
-55.8%
0.03%
-55.7%
Q3 2019$3,253,000
+17.2%
90,400
-12.9%
0.06%
+29.8%
Q2 2019$2,775,000
-0.4%
103,8000.0%0.05%
-69.3%
Q1 2019$2,787,000
+79.9%
103,800
+8.4%
0.15%
+50.0%
Q4 2018$1,549,000
+30.9%
95,800
+68.1%
0.10%
+36.0%
Q3 2018$1,183,000
+52.4%
57,000
+65.0%
0.08%
-2.6%
Q1 2018$776,000
-26.4%
34,550
-1.4%
0.08%
-30.0%
Q4 2017$1,055,000
-76.1%
35,050
-70.0%
0.11%
-76.1%
Q3 2017$4,407,000
-24.7%
117,000
-37.1%
0.46%
-33.4%
Q2 2017$5,854,000
+278.4%
186,000
+313.3%
0.69%
+235.9%
Q1 2017$1,547,000
+19.2%
45,0000.0%0.21%
-22.6%
Q4 2016$1,298,000
-9.3%
45,0000.0%0.27%
+2.7%
Q3 2016$1,431,000
-2.1%
45,0000.0%0.26%
-5.8%
Q2 2016$1,461,000
+16.1%
45,0000.0%0.28%
+20.6%
Q1 2016$1,258,00045,0000.23%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Finepoint Capital LP 556,553$11,598,5655.78%
Baker Brothers Advisors 42,864,612$893,298,5145.15%
RTW INVESTMENTS, LP 11,576,537$241,255,0315.09%
Palo Alto Investors LP 2,405,793$50,136,7264.74%
Birchview Capital, LP 240,400$5,009,9364.26%
EcoR1 Capital, LLC 5,991,479$124,862,4224.21%
EMERALD ADVISERS, LLC 1,681,052$35,033,1241.70%
EMERALD MUTUAL FUND ADVISERS TRUST 1,303,988$27,175,1101.64%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 179,702$3,739,5991.26%
SECTOR GAMMA AS 179,785$3,746,7190.96%
View complete list of ACADIA PHARMACEUTICALS INC shareholders